| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |